+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical effect and mechanismn of xuefu zhuyu capsule in treating unstable angina pectoris



Clinical effect and mechanismn of xuefu zhuyu capsule in treating unstable angina pectoris



Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 29(1): 65-68



To observe the clinical effect of Xuefu Zhuyu Capsule (XFZYC) in treating unstable angina pectoris (UAP) and to investigate its mechanism of protection on vascular endothelia. Sixty UAP patients were randomly assigned to two groups, the 30 in the treated group were treated by conventional therapy plus XFZYC, and the 30 in the control group treated by conventional therapy alone. The frequency and persistent time of angina pectois, dosage of nitroglycerin used, changes of electrocardiogram (ECG) were observed, and the plasma levels of endothelin (ET), nitric oxide (NO), von Willebrand factor (vWF), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular adhesion molecule-1 (sICAM-1) were tested before and after the two-month therapeutic course. (1) The clinical symptoms as frequency and persistent time of angina pectoris in the treated group were bettered significantly after treatment and the dosage of nitroglycerin used decreased (all P < 0.01), showing significant difference when compared with those in the control group (P < 0.05). (2) The effective rates on UAP symptoms and ECG in the treated group were 86.7% and 76.7% respectively, which were significantly higher than those in the control group (70.0% and 63.3%, P < 0.05). (3) Laboratory examination showed in the control group, changes only displayed in the decrease of vWF and ET and increase of NO (all P < 0.05), while in the treated group, plasma levels of vWF, ET, sVCAM-1 and sICAM-1 after treatment significantly decreased and were lower than those in the control group (P < 0.01), but NO elevated significantly and was higher than that in the control group (P < 0.01). XFZYC is an effective Chinese patent medicine for treatment of UAP. It displays its effect on protecting vascular endothelia and anti-angina pectoris partially by decreasing the plasma levels of ET, vWF, sVCAM-1 and sICAM-1 and elevating the level of NO.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052114579

Download citation: RISBibTeXText

PMID: 19338157


Related references

Chinese patent medicine Xuefu Zhuyu capsule for the treatment of unstable angina pectoris: A systematic review of randomized controlled trials. Complementary Therapies in Medicine 22(2): 391-399, 2015

Effect of Xuefu Zhuyu pill on platelet activating factor expression in patients with unstable angina pectoris. Chinese Journal of Integrative Medicine 8(4): 267-270, 2002

Effects of xuefu zhuyu decoction on functions of vascular endothelium in patients with unstable angina pectoris. Zhong Xi Yi Jie He Xue Bao 4(3): 256-259, 2006

The effects of xuefu zhuyu and shengmai on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris after percutaneous coronary intervention: a randomised controlled clinical trial. Evidence-Based Complementary and Alternative Medicine 2013: 896467, 2013

Clinical study of purified xuefu capsule in treating angina pectoris. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 18(7): 399-401, 2001

Effect of Xuefu Zhuyu Capsule (血府逐瘀胶囊) on the symptoms and signs and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: A Randomized controlled trial. Chinese Journal of Integrative Medicine 16(5): 399-405, 2011

Evaluation on effects of disassembled formulas of Xuefu Zhuyu Decoction for treatment of angina pectoris using Seattle Angina Questionnaire. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 27(1): 18-20, 2007

GW25-e3314 Clinical application of treating different diseases with the same method - Xuefu Zhuyu Capsule (a traditional Chinese patent medicine) for blood stasis syndrome. Journal of the American College of Cardiology 64(16): C208-C209, 2014

The usefulness of xuefu zhuyu tang for patients with angina pectoris: a meta-analysis and systematic review. Evidence-Based Complementary and Alternative Medicine 2014: 521602, 2014

Clinical observation on effect of xuefu zhuyu decoction in treating patients with liver fibrosis caused by chronic hepatitis B. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 24(11): 983-985, 2004

Effectiveness and safety of Xuefu Zhuyu decoction for treating coronary heart disease angina: A systematic review and meta-analysis. Medicine 98(9): E14708, 2019

Clinical observation of the effect of shuxinsu capsule in treating angina pectoris. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 19(11): 656-659, 2002

Effect of xuefu zhuyu capsule on immunologic function in mice. Tianjin Medical Journal 15(9): 544-547, 1987

Effect of Xuefu Zhuyu Capsule () on Angiogenesis in Hindlimb Ischemic Rats. Chinese Journal of Integrative Medicine 2019, 2019

Moderate Angiogenic Effect of Xuefu Zhuyu Capsule by Regulating EphB4/EphrinB2. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 37(2): 209-214, 2017